Skip to main content
. 2022 Jul 11;10(7):1668. doi: 10.3390/biomedicines10071668

Figure 2.

Figure 2

Receiver operating characteristics curves for prediction of death within 1 year of (A) HDL-apoA-II, (B) HDL2-apoA-II, or (C) HDL3-apoA-II.